August, 2025
Nathan Smith
The NSB board brings a wealth of experience in biopharmaceuticals, commercial medical and corporate leadership.
August, 2025
Nathan Smith
July, 2024
Rob McKenzie
July, 2024
Paul Fry
June, 2021
Anton Uvarov
July, 2024
Clarke Barlow
July, 2024
Chris Achurch